Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition.
Zhang H, Cohen AL, Krishnakumar S, Wapnir IL, Veeriah S, Deng G, Coram MA, Piskun CM, Longacre TA, Herrler M, Frimannsson DO, Telli ML, Dirbas FM, Matin AC, Dairkee SH, Larijani B, Glinsky GV, Bild AH, Jeffrey SS.
Zhang H, et al. Among authors: cohen al.
Breast Cancer Res. 2014 Apr 7;16(2):R36. doi: 10.1186/bcr3640.
Breast Cancer Res. 2014.
PMID: 24708766
Free PMC article.